Therapeutic Efficacy of Third-Generation Percutaneous Vertebral Augmentation System (PVAS) in Osteoporotic Vertebral Compression Fractures (OVCFs): A Systematic Review and Meta-analysis.

Biomed Res Int · 2022 · PMC9107362 · PMID 35578725

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

slightly significantP = 0.05actually significant

Overall, the summarized estimate of effect size indicated a slightly significant difference between the two groups (RR = 0.82, 95% CI 0.67 to 1.00, P = 0.05, Figure 7(a) ), which favored the third-generation PVAS, with moderate heterogeneity ( I 2 = 44%, P = 0.08).

also in 1,762 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.